Effects of light therapy on sleep and circadian rhythm in older type 2 diabetics living in long-term care facilities: a randomized controlled trial

被引:1
作者
Wang, Qin [1 ,2 ]
Wu, Shuang [1 ]
Luo, Zhenhua [3 ]
Pu, Lihui [4 ,5 ]
Wang, Xiaoxia [1 ]
Guo, Maoting [1 ]
Zhang, Mingjiao [1 ]
Tang, Hongxia [1 ]
Chen, Mengjie [1 ]
Kong, Laixi [1 ]
Huang, Ping [2 ]
Chen, Liyuan [2 ]
Li, Zhe [6 ,7 ]
Zhao, Dan [1 ]
Xiong, Zhenzhen [1 ,8 ]
机构
[1] Chengdu Med Coll, Sch Nursing, Chengdu, Sichuan, Peoples R China
[2] Polus Int Coll, Sch Hlth & Med, Chengdu, Sichuan, Peoples R China
[3] First Affiliated Hosp Tradit Chinese Med, Affiliated Hosp Tradit Chinese Med 1, Chengdu Med Coll, Chengdu, Sichuan, Peoples R China
[4] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia
[5] Griffith Univ, Sch Nursing & Midwifery, Brisbane, Qld, Australia
[6] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China
[7] Sichuan Clin Med Res Ctr Mental Disorders, Chengdu, Sichuan, Peoples R China
[8] Nursing Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
关键词
older adults; long-term care facility; type; 2; diabetes; light therapy; sleep disturbance; circadian rhythm; BRIGHT LIGHT; HUMAN MELATONIN; GANGLION-CELLS; QUALITY; DEMENTIA; DISTURBANCES; MOOD; SENSITIVITY; RESIDENTS; EXPOSURE;
D O I
10.3389/fendo.2024.1307537
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Light influences the secretion of melatonin in the body and regulates circadian rhythms, which play an important role in sleep and mood. The light level of rooms in long-term care facilities is usually far below the threshold required to regulate the body's circadian rhythm, and insufficient light can easily lead to sleep and mood disturbances among older residents in nursing homes. Therefore, the objective of this study was to investigate the effects of light therapy on sleep and circadian rhythm in older adults with type 2 diabetes residing in long-term care facilities.Methods This study was a prospective, single-blind, randomized controlled trial. Participants were randomly assigned to either the light therapy (LT) group or the control group and received the intervention for four weeks. Primary outcomes included the Pittsburgh Sleep Quality Index (PSQI) and objective sleep parameters recorded by a sleep monitoring bracelet, Morningness-Eveningness Questionnaire (MEQ). The secondary outcome included glycated serum protein (GSP). Data was collected at three time points: at baseline (T0), immediate post-treatment (T1), and 4-week follow-up (T2). A linear mixed model analysis was used to analyzed the data.Results We enrolled 45 long-term care residents. Compared with the control group, significant reductions in PSQI scores were observed at T1 and T2. At T2, the sleep score of objective sleep parameters was significantly higher in the LT group compared to the control group. Additionally, compared to the baseline T0, MEQ scores were significantly lower in the LT group at T1 and T2, with no significant difference in the control group. There was no significant difference between groups in glycated serum protein values at T1 and T2. However, compared to T0, glycated serum protein values decreased in the LT group while increased in the control group at T2.Conclusion Light therapy had a positive effect on subjective sleep quality and circadian rhythm time type in long-term care residents with type 2 diabetes, and had a possible delayed effect on objective sleep. However, no discernible alterations in blood glucose levels were detected in this study.
引用
收藏
页数:12
相关论文
共 71 条
  • [1] Supplemental light exposure improves sleep architecture in people with type 2 diabetes
    Adhikari, Prakash
    Pradhan, Asik
    Zele, Andrew J.
    Feigl, Beatrix
    [J]. ACTA DIABETOLOGICA, 2021, 58 (09) : 1201 - 1208
  • [2] Cardiopulmonary Sleep Spectrograms Open a Novel Window Into Sleep Biology-Implications for Health and Disease
    Al Ashry, Haitham S.
    Ni, Yuenan
    Thomas, Robert J.
    [J]. FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [3] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [4] 2-S
  • [5] Ancoli-Israel Sonia, 2003, Behav Sleep Med, V1, P22, DOI 10.1207/S15402010BSM0101_4
  • [6] The links between sleep duration, obesity and type 2 diabetes mellitus
    Antza, Christina
    Kostopoulos, Georgios
    Mostafa, Samiul
    Nirantharakumar, Krishnarajah
    Tahrani, Abd
    [J]. JOURNAL OF ENDOCRINOLOGY, 2022, 252 (02) : 125 - 141
  • [7] Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
    Atkin, Tobias
    Comai, Stefano
    Gobbi, Gabriella
    [J]. PHARMACOLOGICAL REVIEWS, 2018, 70 (02) : 197 - 245
  • [8] Baandrup Lone, 2021, Neurobiology of Sleep and Circadian Rhythms, V11, P100067, DOI 10.1016/j.nbscr.2021.100067
  • [9] Beerenwinkel N, 2012, METHODS MOL BIOL, V855, P77, DOI 10.1007/978-1-61779-582-4_3
  • [10] Phototransduction by retinal ganglion cells that set the circadian clock
    Berson, DM
    Dunn, FA
    Takao, M
    [J]. SCIENCE, 2002, 295 (5557) : 1070 - 1073